Ponatinib strikingly inhibited the growth of both WT and T674I FIP1L1-PDGFRα-carrying CEL cells (IC50: 0.004–2.5 nM). This evidence concerns the gene FIP1L1 and Chronic Eosinophilic Leukemia, Not Otherwise Specified.